Background: Given the great technical difficulty and procedural complexity of laparoscopic total gastrectomy (LTG), the technical and oncologic safety of LTG versus open total gastrectomy (OTG) in the field of advanced gastric cancer (AGC) is yet undetermined.

Objective: This multicenter cohort study aimed to compare the surgical and oncological outcomes of LTG with those of OTG in AGC patients.

Patients And Methods: In total, 588 patients from 3 centers who underwent primary total gastrectomy with D2 lymphadenectomy, by well-trained surgeons with adequate experience, for pathologically confirmed locally AGC (T2N0-3, T3N0-3, or T4N0-3) between January 1, 2011, and December 31, 2015, were identified, and their clinical data were collected from three participating centers. After 1:1 propensity score matching (PSM), 450 cases (LTG, n = 225; OTG, n = 225) were eligible and assessed.

Results: No significant difference in the number of retrieved lymph nodes, 5-year disease-free survival (DFS) rates, or 5-year overall survival (OS) rates between both surgical groups were observed. Although LTG had significantly longer surgical time (262 vs. 180 min, < 0.001), LTG was associated with fewer postoperative complications [relative risk (RR) 0.583, 95% CI 0.353-0.960, = 0.047), less intraoperative bleeding (120 vs. 200 ml, < 0.001), longer proximal margin resection (3 vs. 2 cm, < 0.001), and shorter postoperative hospitalization (11 vs. 13 days, < 0.001). The mortality rate was comparable in both groups.

Conclusions: LTG was not inferior to OTG in terms of survival outcomes and was associated with shorter surgical and postoperative hospitalization time and fewer postoperative complications, suggesting LTG with D2 lymphadenectomy as an important alternative to OTG for patients with AGC, but to be carried out in highly experienced centers.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710448PMC
http://dx.doi.org/10.3389/fonc.2021.780398DOI Listing

Publication Analysis

Top Keywords

total gastrectomy
16
versus open
8
open total
8
advanced gastric
8
gastric cancer
8
cohort study
8
ltg
8
fewer postoperative
8
postoperative complications
8
postoperative hospitalization
8

Similar Publications

Postoperative leaks after sleeve gastrectomy are a troublesome complication that occur in 0.7-5.3% of cases depending on the referenced source.

View Article and Find Full Text PDF
Article Synopsis
  • Metabolic and Bariatric Surgery (MBS) for adolescents has been made more accessible due to recent policy changes, but challenges remain, particularly for diverse populations.
  • A study from 2017-2022 revealed that about 15%-20% of MBS cases in the U.S. involved adolescents, predominantly females and white patients with an average age of 16.1 years.
  • Despite a decline in cases during COVID-19, the volume rebounded, with an increase in sleeve gastrectomy and robotic-assisted surgeries, while overall complication rates remained low at 2.9%.
View Article and Find Full Text PDF

Risk assessment for esophageal cancer after bariatric surgery: a comparative cohort study between sleeve gastrectomy and gastric bypass.

Surg Obes Relat Dis

December 2024

Department of Digestive Surgery, Magellan Center, Bordeaux University Hospital Pessac, Bordeaux, France; BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, Univ. Bordeaux, Bordeaux, France. Electronic address:

Background: The risk of esophageal cancer after bariatric surgery is a matter of debate.

Objective: This study aims to evaluate the risk of esophageal cancer following sleeve gastrectomy (SG) and gastric bypass (GB).

Methods: We extracted data from the national discharge database (Programme De Médicalisation des Systèmes d'Information) for patients who underwent bariatric surgery in France between 2007 and 2020.

View Article and Find Full Text PDF

Background: Bariatric surgery is the most effective intervention for severe pediatric obesity, but a subset of youth experience suboptimal weight loss and/or recurrent weight gain. Early re-initiation of obesity pharmacotherapy postoperatively may improve outcomes, though this has not been evaluated in pediatric populations.

Methods: A retrospective cohort study at a tertiary care children's hospital evaluated the safety and efficacy of reintroducing obesity pharmacotherapy within six weeks after laparoscopic sleeve gastrectomy (LSG).

View Article and Find Full Text PDF

Usefulness of Serum Biomarkers in Predicting Anastomotic Leakage After Gastrectomy.

Cancers (Basel)

January 2025

Biomedical Research Group on Biomaterials and Wound Healing (Ciber-BBN), Traslational Research and Innovation in General and Digestive Surgery (Idipaz), 28046 Madrid, Spain.

Background/objectives: Anastomotic leakage (AL) is one of the most concerning complications following gastrectomy. The aim of this study was to assess and compare the predictive accuracy of C-reactive protein (CRP), procalcitonin (PCT), the neutrophil-to-lymphocyte ratio (NLR), the platelet-to-lymphocyte ratio (PLR), fibrinogen, and the mean platelet volume (MPV) in the early diagnosis of post-gastrectomy AL.

Methods: A prospective bicentric observational study was conducted including all patients undergoing elective gastrectomy between August 2018 and December 2022.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!